The authors demonstrated that this mutation did not cause appreciable NMD, and transcript expression in tissue culture cells and translation in vitro revealed that alternative in-frame translation start sites involving Met113 and possibly Met233 were used to generate truncated RB1 products (pRB94 and pRB80), known and suspected to exhibit tumor suppressor activity [27]. Here, RB1 is linked to neoplasm.